Search results

1. Mr Oscar Baldwin

   ... disease and its rarity. My work aims at understanding the events that allow the normal developing choroid plexus epithelium to transform ...

2. Dr Saif Ahmad

   I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's lab. My research is focused on understanding a novel mechanism by which the BRCA2 tumour suppressor protein...

3. Dr Sujath Abbas

   ... (OAC), where I investigated the dynamics of mutational events during the development and spread of OAC. Also, along with colleagues I ...

4. Professor Walid Khaled

   ... works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on ...

5. Dr David Gilligan

   David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

6. Mr David Thurtle

   Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

7. Dr Roisin Owens

   Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

8. Mr Thierry Lefebvre

   Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

9. Mr Alexander Evtushenko

10. Mr Asif Jah

    Mr Asif Jah ...

11. Dr Callum Campbell

12. Dr Cedric Ghevaert

    Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of...

13. Ms Christine Anne Loreno

14. Miss Daniella Black

15. Dr David Fernandez-Antoran

    We use long-term human and mouse 3D primary epithelial cultures,  in vivo  cell lineage tracing, mathematical modelling, next generation sequencing methods and state-of-the-art confocal microscopy techniques to unravel the molecular responses and...

16. Dr Dominic Gerard O'Donovan

    Corneal Pathology & Transplantation Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

17. Miss Emma Brown

18. Miss Emma Wong

19. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

20. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

21. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

22. Dr Alasdair Russell

    Alasdair heads up a specialised team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. Further, we use these novel...

23. Dr Alexey Larionov

    Hormonal treatment and resistance in Breast cancer Heritable cancer predisposition NGS data analysis

24. Dr Andrew Bannister

    I have spent the last three decades generally messing around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone modifications together with characterization of the enzymes ...

25. Dr Antony Rix

    Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...

26. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

27. Dr Alex Cagan

    My research seeks  to understand the somatic evolutionary processes that occur within our bodies as we age and their consequences for health.  Evolution is often considered  to be an almost imperceptibly slow process. However, the cells that...

28. Dr Andre Neves

    As a chemical engineer, I enjoy translating basic science into novel biomedical technologies. I am interested in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm...

29. Professor Duncan Jodrell

    ... my effort now focussing on pancreatic cancer. An overview of pancreatic ductal adenocarcinoma and current drug treatment ...

30. Dr Ali Amin Al Olama

    ... genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer ...

31. Mr Angelos Kolias

    ... base/pituitary, he is working on i) the development of a core outcome set for pituitary surgery and ii) the implementation and ...

32. Mrs Coreen DSouza

33. Mr David Chalmers

    ... software services and applications for the Research Groups, Core Facilities and Operations departments. ...

34. Dr Daniel Hodson

    Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas (including follicular, diffuse large B cell and Burkitt lymphomas) develop from a specific stage of B lymphocyte differentiation termed the Germinal Centre. ...

35. Dr Dominick McIntyre

    Head of the CRUK CI Imaging Core Facility, specialising in preclinical MRI and image databases, and running ...

36. Dr Daniel Barnes

    My research focuses on the statistical analyses of BRCA1 and BRCA2 gene mutation carriers, primarily through data obtained by the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) consortium. These individuals are at increased risk of breast...

37. Mr Richard Grenfell

    Flow cytometry core facility ...

38. Dr Inigo Martincorena

    My research focuses on understanding cancer progression as a result of somatic mutation and selection. Over the past few years, systematic sequencing of tumours has revolutionised our understanding of the genetics of cancer. This has revealed that most...

39. Dr James Hadfield

    ... in touch. PS: I previously managed the CRUK-CI Genomics Core. ...

40. Professor Ben Simons

    ... maintenance in mouse. Currently, we are extending these ideas to explore cell fate in human epidermis addressing both normal and ...

41. Professor Gillian Murphy

    ... of specific enzyme domains has also generated novel ideas for the production of novel inhibitors. ...

42. Dr Alejandra Bruna

    ... aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in ... of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the molecular heterogeneity present in primary ...

43. Professor Antonis Antoniou

    ... component; - the identification and characterisation of cancer risks for genetically susceptible individuals, such as those carrying ...

44. Dr Catherine Lindon

    ... to coordinated cell division, and have well documented cancer-promoting activities. Ongoing projects in the lab explore how ... in time and space, and how their activity contributes to cancer. We have recently described a 'ubiquitome' of cellular components ...

45. Dr Alison Dunning

    Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput ... (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response. In this we collaborate closely ... consortia for breast, ovarian, endometrial and prostate cancer association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, CIMBA ...

46. Dr Ashray Gunjur

    ... broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David ... between gut microbiota and outcomes in patients with rare cancer types. ...

47. Dr Ahsan MEMON

    ... this holographic system was deployed to the study of cancer and stem cell shape regulation and the role of effective membrane ...

48. Dr Aisling Redmond

    ... She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), ...

49. Dr Ashwin Seshia

    One of the research thrusts in my group is the development of microelectromechanical and microfluidics based platforms for early diagnosis. We also research microfabricated biophysical tools to characterise biological systems ...

50. Dr Adrien Hallou

    ... PhD in Biophysics at the University of Cambridge. I am now a Research Fellow at Darwin College and a Herchel Smith Research Fellow in the group of Professor Benjamin Simons, where my work ...

51. Dr Adrian Ionescu

    I currently work as a post-doctoral research associate at the Cavendish Laboratory, Department of Physics, ... of contemporary experimental condensed matter physics research including spintronics, surface science, magnetism at the nanoscale and ... strong track record with international recognition in these research areas, with 50 publications and two books to date. With some of these ...

52. Dr Alexandre Kabla

    My main research activities focus on the mechanical properties of soft disordered ...

53. Professor Anna Korhonen

    I conduct research in computer science - in natural language processing and text mining. I have research projects which focus on biomedical text processing and mining, e.g. ... develops text mining technology for the needs of cancer research. ...

54. Mr Aman Coonar

    Clinical research in thoracic cancer with emphasis on surgery. Local PI for PULMICC ...

55. Mr Amit Roshan

    ... with a clinical interest in early stage melanoma. My research focus is currently exploring the utility of circulating tumour DNA ...

56. Professor Andrew Flewitt

    ... thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic ...

57. Professor Anna Philpott

    ... a disease of differentiation. Ultimately, our studies on these fundamental mechanisms that co-ordinate proliferation and differentiation ...

58. Dr Basma Greef

    ... of hypoxia response pathways in renal cancer and how these can be harnessed to develop new treatments. My other interests include ...

59. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the ...

60. Miss Amara Cañizares

61. Dr Fazlur Rahman Talukdar

    ... (IARC-WHO), France, in 2015. During this tenure, my research aimed to identify DNA methylome alterations linked to esophageal cancer within ...

62. Dr Kerstin Meyer

    ... analysis of predisposition loci: My experiments are aimed at understanding the mechanisms by which breast cancer risk loci ...

63. Dr Misha Kapushesky

    ... a universal ecosystem for bioinformatics development, aimed to reduce the chaotic clutter of inefficiency and incompatibility in ...

64. Dr Nicholas Walton

    ... currently aiding in their search for new techniques aimed at the treatment of breast cancer. ...

65. Professor Rahul Roychoudhuri

    ... providing targets for development of new therapies aimed at reversing dysfunctional immune responses in cancer. ...

66. Dr Bristi Basu

    ... Phase I, II and III clinical trials, including first-in-human and first-in-class studies. My tumour site-specific focus is in ...

67. Professor Tim Eisen

    ... where I am currently responsible for oncology trials from first in man to Phase II. ...

68. Dr Elisa Laurenti

    ... As perturbation of HSC regulatory networks drives the first steps of leukaemia, knowledge of HSC specific molecular responses will ...

69. Dr Kelly Holmes

    ... CRUK Cambridge Centre Imaging Programme Manager. Kelly has a first class degree in Biochemistry with a year in industry. She completed her ...

70. Dr Laura Blackburn

    ... research and held a workshop on the implementation of the first ctDNA testing services in the NHS, which were facilitating treatment ...

71. Dr Lori Passmore

    ... of translation to control gene expression, and is the first step in mRNA turnover. The major deadenylase activities are found within ...

72. Dr David Adams

    ... data for over 200 genetically modified mouse lines per year to gain a better understanding of mammalian gene function. ...

73. Dr Joanna Baxter

    The Cambridge Blood and Stem Cell Biobank is a facility of over 6000 viable and nucleic acid samples, the majority from patients with haematological malignancy and clonal blood cell disorders; and the remainder, around 20%, from normal individuals,...

74. Mrs Eva Serrao

    Despite medical advances, pancreatic cancer still has a 5-year survival rate of less than 6%. The ideal way to improve this is to ...

75. Dr Hayley Woffendin

    After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...

76. Dr Hannah Harrison

    Since moving into public health research around 5 years, Hannah has been involved in projects investigating risk-stratification for kidney cancer screening and follow-up. Her most rencet project, funded by CRUK, is investigating multifactorial models...

77. Dr Amos Burke

    ... and currently co-supervises a Clinical and a basic science PhD student. At a national level Dr Burke is the National Institute for Health ...

78. Miss Annalisa Occhipinti

    I am a Mathematician and I am doing a PhD in bioinformatics at the University if Cambridge. I am currently working on ...

79. Ms Ceilidh Welsh

    I am a PhD student working with  Cancer Research UK RadNet Cambridge Radiation ...

80. Dr Danish Mazhar

    ... and Charing Cross Hospitals in London. He was awarded a PhD by Imperial College London for his research in Prostate Cancer. He has also ...

81. Dr Emmanuel Huguet

    ... undergraduate medical students. He subsequently undertook a PhD in cancer molecular biology at Oxford University in the laboratories of the ...

82. Professor Eamonn Maher

    ... and non-clinician scientists and had supervised more than 25 PhD or MD students to completion. Current research in Eamonn?s group relates to ...

Pages